Drug Shortage Report for APO-TERBINAFINE
Report ID | 75632 |
Drug Identification Number | 02239893 |
Brand name | APO-TERBINAFINE |
Common or Proper name | TERBINAFINE |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | TERBINAFINE |
Strength(s) | 250MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 30BLS and 100 BTL |
ATC code | D01BA |
ATC description | ANTIFUNGALS FOR SYSTEMIC USE |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-02-11 |
Estimated end date | 2020-08-21 |
Actual end date | 2020-08-07 |
Shortage status | Resolved |
Updated date | 2020-08-10 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2020-08-10 | French | Compare |
v11 | 2020-08-10 | English | Compare |
v10 | 2020-05-27 | French | Compare |
v9 | 2020-05-27 | English | Compare |
v8 | 2020-04-14 | French | Compare |
v7 | 2020-04-14 | English | Compare |
v6 | 2019-05-31 | French | Compare |
v5 | 2019-05-31 | English | Compare |
v4 | 2019-04-26 | French | Compare |
v3 | 2019-04-26 | English | Compare |
v2 | 2019-02-13 | French | Compare |
v1 | 2019-02-13 | English | Compare |
Showing 1 to 12 of 12